ZBH vs MAS stock comparison
Zimmer Biomet vs. Masco · data as of November 13, 2026
Zimmer Biomet (ZBH) has a market value of about $19.5B, Masco (MAS) about $16.3B. Over their latest twelve months Zimmer Biomet had revenue of $8.6B and Masco $7.7B.
On our five checks Masco scores higher: 2.6 out of 5 (average) against 2.2 (weak).
By area, the stronger company is Masco on value; Masco on track record; Zimmer Biomet on financial health.
Masco is cheaper on earnings (P/E 18.3 vs. 26.1), while Zimmer Biomet grew revenue faster over five years (6.1% vs. 1.0% a year).
Zimmer Biomet leads on 9 of the compared lines and Masco on 12.
Side by side
| ZBH | MAS | |
|---|---|---|
| Size and price | ||
| Market cap | $19.5B | $16.3B |
| Share price | $103.21 | $84.68 |
| Score | ||
| Overall score (of 5) | 2.2 | 2.6 |
| Value | 1 | 3 |
| Future growth | 1 | 1 |
| Track record | 1 | 2 |
| Financial health | 3 | 2 |
| Shareholder returns | 5 | 5 |
| Valuation | ||
| P/E (TTM) | 26.1 | 18.3 |
| Forward P/E | 11.4 | 19.8 |
| Price / free cash flow | 11.9 | 15.7 |
| Price / sales | 2.3 | 2.1 |
| EV / EBITDA | 11.7 | 12.6 |
| PEG | — | — |
| DCF value vs. price | −12% | −11% |
| Business | ||
| Revenue | $8.6B | $7.7B |
| Net income | $767M | $926M |
| Free cash flow | $1.6B | $1.0B |
| Net margin | 9.0% | 12.1% |
| Gross margin (5-yr avg.) | 71.0% | 34.5% |
| ROIC (5-yr avg.) | 4.8% | 33.1% |
| Growth | ||
| Revenue growth (1 yr) | 7.2% | -3.4% |
| Revenue growth (5 yrs, per year) | 6.1% | 1.0% |
| EPS growth (5 yrs, per year) | — | -3.4% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$7.1B | -$2.9B |
| Dividend yield | 0.93% | 1.51% |
| Shareholder yield | 3.4% | 5.0% |
| Analysts | ||
| Upside to average target | +13% | −2% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: ZBH TTM to September 30, 2026, MAS TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Zimmer Biomet or Masco?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Masco scores 2.6 out of 5 and Zimmer Biomet 2.2; the table shows where each one is stronger.
Is Zimmer Biomet cheaper than Masco?
On trailing earnings, Masco trades at a P/E of 18.3 and Zimmer Biomet at 26.1, so Masco is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Zimmer Biomet or Masco?
Over five years Zimmer Biomet grew revenue about 6.1% a year and Masco about 1.0% a year.
Which pays a higher dividend?
Zimmer Biomet yields 0.93% and Masco 1.51%.
Full Zimmer Biomet analysis → Full Masco analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.